Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5879 posts found.

NICE updates guidelines on atrial fibrillation based on new evidence

April 27, 2021 Manufacturing and Production NICE

NICE has updated its guideline on the diagnosis and management of atrial fibrillation (AF) based on new evidence found since …
News
csm_pharma-lohnherstellung_84edd19f2d

Hilco Industrial acquires all machinery and equipment from Legacy Pharmaceutical Switzerland

April 27, 2021 Manufacturing and Production

Hilco Industrial Acquisitions, an Amsterdam based industrial asset disposition and acquisition company, has acquired all machinery and equipment from the …
News

Data published on novel molecules for leukaemia treatment

April 27, 2021 Manufacturing and Production oncology

STORM Therapeutics have published new data in Nature on targeting RNA modifying enzymes for the development of new anti-cancer therapeutics, …
News

Home breast cancer treatment offered in UK for first time

April 27, 2021 Manufacturing and Production

Phesgo, a treatment for breast cancer, will now be offered to patients at home in the UK for the very …
News

Adagio raises $336 million to advance COVID-19 antibody

April 20, 2021 Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news

Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …
News

Oxford University & Prenetics to collaborate on global rapid testing tech

April 20, 2021 Manufacturing and Production

The University of Oxford, Prenetics Limited and the Oxford Suzhou Centre for Advanced Research (OSCAR) have signed collaboration agreements to …
News
credit_-_crevis_shutterstock_340710245_720

Enhertu now available via Cancer Drugs Fund following NICE decision

April 20, 2021 Manufacturing and Production AstraZeneca, breast cancer, oncology

AstraZeneca and Daiichi Sankyo have announced that NICE has approved Enhertu (trastuzumab deruxtecan) for use within the Cancer Drugs Fund …
News

Novartis multiple sclerosis treatment recommended by NICE

April 20, 2021 Manufacturing and Production NICE, Novartis, multiple sclerosis, pharma, pharma news

NICE have recommenced Novartis’ ofatumumab (Kesimpta) for the treatment of relapsing remitting MS (RRMS) in adult patients for use on …
News

Avacta’s COVID-19 lateral flow test gains clinical validation

April 20, 2021 Manufacturing and Production COVID-19

Avacta have announced positive data from the clinical validation of its AffiDX SARS-CoV-2 antigen lateral flow test, based on a …
News
AstraZeneca sign

AstraZeneca’s Farxiga falls short in Phase III trials for treatment of COVID-19

April 13, 2021 Manufacturing and Production AstraZeneca, COVID-19, covid-19 treatment, farxiga, pharma, pharma news

AstraZeneca’s Farxiga drug, usually used in patients with diabetes, did not show statistical significance in the Phase III trial into …
News

Regeneron’s drug cocktail shown to prevent symptomatic COVID-19

April 13, 2021 Manufacturing and Production COVID-19, REGEN-COV, Regeneron, covid-19 treatment, pharma, pharma news

Regeneron’s REGEN-COV treatment cocktail for COVID-19, a combination between casirivimab and imdevimab, has shown a significant reduction in progression to …
News
pexels-lucy-6816451_cropped

Asthma drug Budesonide helps COVID-19 recovery at home

April 13, 2021 Manufacturing and Production COVID-19, asthma drug

Budesonide, a widely-used asthma drug, is the first treatment to be proven to speed up the recovery of COVID-19 patients …
News

BC Platforms partners with Australian Tissue Bank to improve breast cancer treatment

April 13, 2021 Manufacturing and Production Cancer, data

BC Platforms have announced a data partnership with the Australian Breast Cancer Tissue Bank (ABCTB) for its BCRQUEST.com Global Data …
News

Akari Therapeutics open IND with FDA for bullous pemphigoid treatment

April 13, 2021 Manufacturing and Production FDA

Akari Therapeutics have opened an investigational new drug application (IND) with the FDA for its multicentre Phase III study with …
News

Intravac appoints Nathalie Laarakker as CFO

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team. …
Appointment
The Gateway to Local Adoption Series

Latest content

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026